Patent license for the production, and commercialization of herbal products.
We are leasing a patent license for the herbal formula developed by us to treat Covid-19 and other viral/respiratory illnesses.
Formulations can be used safely on adults and children (3yrs +).
Patent includes research, two herbal formulations, and a unique intermittent fasting method designed to quickly rid the body of toxins.
Currently in the pre-IND phase with the U. S. FDA for clinical trials.
Advance payment for the patent of USD $20 million,
10% royalties thereafter for 10-20 year term (negotiable).
Potential companies must have a solid track record in the nutraceutical industry, strong supply chain, and the ability to reach emerging markets for traditional medicine particularly in China and India.
Additional information is available upon request and after signing the NDA.
0
0
0
0
0